accountagainst unfractionated heparin + GPIIb/IIIa inhibitors is a real contribution to interventional cardiology in the contemporary era of evidence based medicine' said Professor Gilles Montalescot of the Pitié-Salpêtrière Hôpital, France. Previous...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The Medicines Company Announces Positive CHMP Opinion for Angiox® (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
